Patents by Inventor Duojia Pan

Duojia Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11491139
    Abstract: Yes-associated protein (Yap), a downstream co-activator of the Hippo pathway, is highly expressed in the Treg cell subset, and is critical to maintain its suppressive activity. Originally discovered in Drosophila melanogaster, the Hippo signaling pathway is a major regulator of cellular growth and proliferation in mammals. Loss of Yap expression in Treg cells can lead to superior anti-tumor immune responses, and thus, Yap is an important immunotherapeutic target for cancer.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: November 8, 2022
    Assignee: The Johns Hopkins University
    Inventors: Fan Pan, Duojia Pan, Drew M. Pardoll, Joseph Barbi, Benjamin Park
  • Publication number: 20220112279
    Abstract: The present invention relates to compositions and methods for treating cancer by targeting the Activin signaling pathway. In certain embodiments, combining Activin blockade with immunomodulation alters regulatory T (Treg) cell-mediated immune regulation and treats cancer.
    Type: Application
    Filed: December 23, 2021
    Publication date: April 14, 2022
    Inventors: Fan Pan, Duojia Pan, Drew M. Pardoll, Joseph Barbi, Juan Fu
  • Patent number: 11236156
    Abstract: The present invention relates to compositions and methods for treating cancer by targeting the Activin signaling pathway. In certain embodiments, combining Activin blockade with immunomodulation alters regulatory T (Treg) cell-mediated immune regulation and treats cancer.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: February 1, 2022
    Assignee: The Johns Hopkins University
    Inventors: Fan Pan, Duojia Pan, Drew M. Pardoll, Joseph Barbi, Juan Fu
  • Publication number: 20190077855
    Abstract: The present invention relates to compositions and methods for treating cancer by targeting the Activin signaling pathway. In certain embodiments, combining Activin blockade with immunomodulation alters regulatory T (Treg) cell-mediated immune regulation and treats cancer.
    Type: Application
    Filed: February 10, 2017
    Publication date: March 14, 2019
    Applicant: The Johns Hopkins University
    Inventors: Fan Pan, Duojia Pan, Drew M. Pardoll, Joseph Barbi, Juan Fu
  • Publication number: 20190046583
    Abstract: The present invention relates to novel compositions and methods to produce 3D organ equivalents of the brain (i.e. “mini-brains”). The invention also relates to methods of using human induced pluripotent stem cells, a combination of growth and other soluble factors and gyratory shaking. Cells from healthy or diseased donors or animals can be used to allow testing different genetic backgrounds. The model can be further enhanced by using genetically modified cells, adding micro-glia or their precursors or indicator cells (e.g. with reporter genes or tracers) as well as adding endothelial cells to form a blood-brain-barrier.
    Type: Application
    Filed: February 10, 2017
    Publication date: February 14, 2019
    Applicant: Johns Hopkins Technology Ventures
    Inventors: Fan Pan, Duojia Pan, Drew M. Pardoll, Joseph Barbi, Juan Fu
  • Publication number: 20180021306
    Abstract: Yes-associated protein (Yap), a downstream co-activator of the Hippo pathway, is highly expressed in the Treg cell subset, and is critical to maintain its suppressive activity. Originally discovered in Drosophila melanogaster, the Hippo signaling pathway is a major regulator of cellular growth and proliferation in mammals. Loss of Yap expression in Treg cells can lead to superior anti-tumor immune responses, and thus, Yap is an important immunotherapeutic target for cancer.
    Type: Application
    Filed: February 12, 2016
    Publication date: January 25, 2018
    Inventors: Fan PAN, Duojia PAN, Drew M. PARDOLL, Joseph BARBI, Benjamin PARK
  • Patent number: 7556942
    Abstract: Tumor suppressor genes (TSGs) play a major role in the pathogenesis of human cancers. Here, a new TSG designated hippo (hpo) is described, and the human homolog mst2 is identified as an additional TSG. hpo as a gene that regulates both cell proliferation and cell death in Drosophila, and encodes a Ste-20 family protein kinase that binds to and phosphorylates the tumor suppressor protein Salvador (Sav), which is known to interact with the Warts (Wts) protein kinase. Loss of hpo results in elevated transcription of the cell cycle regulator cyclin E and the cell-death inhibitor diap1, leading to increased proliferation and reduced apoptosis. Further, hpo, sav, and wts define a pathway that regulates diap1 at the transcriptional level. A human homolog of hpo completely rescues the overgrowth phenotype of Drosophila hpo? mutants.
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: July 7, 2009
    Assignee: Board of Regents, The University of Texas System
    Inventor: Duojia Pan
  • Patent number: 7537759
    Abstract: The invention provides methods and compositions relating to Kuz involvement in angiogenesis.
    Type: Grant
    Filed: March 21, 2005
    Date of Patent: May 26, 2009
    Assignee: The Regents of the University of California
    Inventors: Duojia Pan, Gerald M. Rubin, Hongbing Zhang
  • Publication number: 20050171024
    Abstract: The invention provides methods and compositions relating to Kuz involvement in angiogenesis.
    Type: Application
    Filed: March 21, 2005
    Publication date: August 4, 2005
    Inventors: Duojia Pan, Gerald Rubin, Hongbing Zhang
  • Patent number: 6872750
    Abstract: The invention provides methods and compositions relating to Kuz involvement in angiogenesis.
    Type: Grant
    Filed: February 6, 2002
    Date of Patent: March 29, 2005
    Assignee: Regents of the University of California
    Inventors: Duojia Pan, Gerald M. Rubin, Hongbing Zhang
  • Publication number: 20050053592
    Abstract: Tumor suppressor genes (TSGs) play a major role in the pathogenesis of human cancers. Here, a new TSG designated hippo (hpo) is described, and the human homolog mst2 is identified as an additional TSG. hpo as a gene that regulates both cell proliferation and cell death in Drosophila, and encodes a Ste-20 family protein kinase that binds to and phosphorylates the tumor suppressor protein Salvador (Sav), which is known to interact with the Warts (Wts) protein kinase. Loss of hpo results in elevated transcription of the cell cycle regulator cyclin E and the cell-death inhibitor diap1, leading to increased proliferation and reduced apoptosis. Further, hpo, sav, and wts define a pathway that regulates diap1 at the transcriptional level. A human homolog of hpo completely rescues the overgrowth phenotype of Drosophila hpo? mutants.
    Type: Application
    Filed: July 15, 2004
    Publication date: March 10, 2005
    Inventor: Duojia Pan
  • Publication number: 20020132778
    Abstract: The invention provides methods and compositions relating to Kuz involvement in angiogenesis.
    Type: Application
    Filed: February 6, 2002
    Publication date: September 19, 2002
    Applicant: The Regents of the University of California
    Inventors: Duojia Pan, Gerald M. Rubin, Hongbing Zhang
  • Publication number: 20020127621
    Abstract: Members of a novel family of polypeptides, the KUZ family, are metalloproteases involved in neuronal partitioning and neuronal development. The invention provides KUZ poylpeptides, antibodies that bind the KUZ polypeptides, KUZ encoding nucleic acids, methods for identifying cells expressing the KUZ polypeptides, methods of identifying ligands that bind to the subject proteins and methods of blocking KUZ polypeptide/ligand interactions.
    Type: Application
    Filed: May 31, 2001
    Publication date: September 12, 2002
    Inventors: Gerald M. Rubin, Duojia Pan, Jenny Rooke, Reza Yavari, Tian Xu
  • Patent number: 6436629
    Abstract: The invention provides methods and compositions relating to Kuz involvement in angiogenesis.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: August 20, 2002
    Assignee: The Regents of the University of California
    Inventors: Duojia Pan, Gerald M. Rubin, Hongbing Zhang
  • Patent number: 6399350
    Abstract: Members of a novel family of polypeptides, the KUZ family, are metalloproteases involved in neuronal partitioning and neuronal development. The invention provides KUZ poylpeptides, antibodies that bind the KUZ polypeptides, KUZ encoding nucleic acids, methods for identifying cells expressing the KUZ polypeptides, methods of identifying ligands that bind to the subject proteins and methods of blocking KUZ polypeptide/ligand interactions.
    Type: Grant
    Filed: May 31, 2001
    Date of Patent: June 4, 2002
    Assignee: The Regents of the University of California
    Inventors: Gerald M. Rubin, Duojia Pan, Jenny Rooke, Reza Yavari, Tian Xu
  • Patent number: 6319704
    Abstract: Members of a novel family of polypeptides, the KUZ family, are metalloproteases involved in neuronal partitioning and neuronal development.
    Type: Grant
    Filed: November 8, 2000
    Date of Patent: November 20, 2001
    Assignees: The Regents of the University of California, Yale University
    Inventors: Gerald M. Rubin, Duojia Pan, Jenny Rooke, Reza Yavari, Tian Xu
  • Patent number: 6190876
    Abstract: Members of a novel family of polypeptides, the KUZ family, are metalloproteases involved in neuronal partitioning and neuronal development. The invention provides KUZ poylpeptides, antibodies that bind the KUZ polypeptides, KUZ encoding nucleic acids, methods for identifying cells expressing the KUZ polypeptides, methods of identifying ligands that bind to the subject proteins and methods of blocking KUZ polypeptide/ligand interactions.
    Type: Grant
    Filed: April 2, 1999
    Date of Patent: February 20, 2001
    Assignees: The Regents of the University of California, Yale University
    Inventors: Gerald M. Rubin, Duojia Pan, Jenny Rooke, Reza Yavari, Tian Xu
  • Patent number: 5935792
    Abstract: Members of a novel family of polypeptides, the KUZ family, are metalloproteases involved in neuronal partitioning and neuronal development.
    Type: Grant
    Filed: August 27, 1997
    Date of Patent: August 10, 1999
    Assignees: The Regents of the University of California, Yale University
    Inventors: Gerald M. Rubin, Duojia Pan, Jenny Rooke, Reza Yavari, Tian Xu